Uromigos Live 2023-Bladder Cancer

The UromigosUromigos Live 2023 | November 20, 2023
The panel discussed the latest updates in NMIBC, including relevant data pertaining to pembro, atezo, and more.
View More
The UromigosUromigos Live 2023 | November 20, 2023
The panel discussed the latest data and updates in frontline bladder cancer during a livestreamed session.
Thomas Powles, MBBS, MRCP, MDUromigos Live 2023 | November 14, 2023
Drs. Powles and Nizam discuss her strategy of intensifying treatment upfront in oligometastatic urothelial carcinoma.
Thomas Powles, MBBS, MRCP, MDUromigos Live 2023 | November 14, 2023
Drs. Powles, Tawagi, and Berg highlight attempts to define 2L SOC options, as well IO rechallenging in bladder cancer.
Pedro Barata, MDUromigos Live 2023 | November 10, 2023
Dr. Pedro Barata discusses his thoughts on the use of cisplatin in patients with bladder cancer, as well as CheckMate 901.
Vadim Koshkin, MDUromigos Live 2023 | November 10, 2023
Dr. Vadim Koshkin gives his thoughts on the CheckMate 901 study and its data that were presented at the conference.
Petros Grivas, MD, PhDUromigos Live 2023 | November 10, 2023
Dr. Petros Grivas discusses new bladder cancer data, including the TAR-200 delivery system and the SunRISe trials.
Mary Beth BallardUromigos Live 2023 | November 10, 2023
Patient advocate Mary Beth Ballard discusses how new research and data gives hope to patients with bladder cancer.
Gautam Jayram, MDUromigos Live 2023 | November 10, 2023
Dr. Gautam Jayram discusses his biggest takeaways from the event, including panels on non-muscle invasive bladder cancer.
Amanda Nizam, MDUromigos Live 2023 | November 8, 2023
Amanda Nizam, MD, discusses her proposed trial examining EV and pembrolizumab in patients with oligometastatic UC.
Karine Tawagi, MDUromigos Live 2023 | November 8, 2023
Dr. Karine Tawagi discusses her proposed trial on a phase 2 multi-arm parallel trial for metastatic UC.
Peter O'Donnell, MDUromigos Live 2023 | November 8, 2023
Dr. O'Donnell shares his impression of the data at ESMO and offers a positive outlook on the future of UC.
Stephanie Berg, DOUromigos Live 2023 | November 8, 2023
Dr. Stephanie Berg describes her presentation given on second-line treatment for mUC during the Rising Stars panel.
Sam Chang, MDUromigos Live 2023 | November 6, 2023
Brian Rini, MD, asks Sam Chang, MD, and Sia Daneshmand, MD, about their takeaways from the session on NMIBC.
Terence Friedlander, MDUromigos Live 2023 | November 6, 2023
Dr. Terence Friedlander provides his take on CheckMate 901 and the enfortumab vedotin/pembrolizumab combination.
The UromigosThe Uromigos | November 6, 2023
Tom is joined by Drs. Chang, Daneshmand, and Grivas to discuss new therapies in NMIBC and BCG-refractory NMIBC.
Shilpa Gupta, MDUromigos Live 2023 | November 6, 2023
Dr. Gupta also discusses upcoming bladder cancer data from ESMO that will influence debate and discussion at the event.
Petros Grivas, MD, PhDUromigos Live 2023 | November 6, 2023
Dr. Petros Grivas shares what data he's most looking forward to discussing at the second Uromigos: Live & Unplugged event.
Advertisement
Advertisement